DeepMed Research

UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

Characteristics of Andersen-Tawil Syndrome

Completed

Conditions: Andersen Syndrome
Andersen-Tawil Syndrome

First Posted Date: 2007-08-28

Last Posted Date: 2013-01-16

Lead Sponsor: University of Rochester

Target Recruit Count: 28

Registration Number: NCT00521794

Locations: 🇬🇧
Institute of Neurology and National Hospital for Neurology, London, United Kingdom
🇮🇹
University of Milan, Milan, Italy
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 4 locations

Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Other: Usual Care
Behavioral: Concurrent Peer Review visit

First Posted Date: 2007-07-27

Last Posted Date: 2013-10-14

Lead Sponsor: University of Rochester

Target Recruit Count: 727

Registration Number: NCT00508014

Locations: 🇺🇸
Westside Health Services, Inc, Rochester, New York, United States

NICU Asthma Education and Secondhand Smoke Reduction Study

Not Applicable

Completed

Conditions: Respiratory Illness

Interventions: Behavioral: Secondhand Smoke Reduction and Smoking Cessation Counseling
Behavioral: Asthma Education

First Posted Date: 2007-07-12

Last Posted Date: 2015-11-23

Lead Sponsor: University of Rochester

Target Recruit Count: 165

Registration Number: NCT00499915

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Trial of Patient Navigation-Activation

Phase 4

Completed

Conditions: Breast Cancer
Colorectal Cancer

Interventions: Behavioral: Navigation
Behavioral: Standard of Care

First Posted Date: 2007-07-04

Last Posted Date: 2013-08-09

Lead Sponsor: University of Rochester

Target Recruit Count: 900

Registration Number: NCT00496678

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Hyper- and Hypokalemic Periodic Paralysis Study

Phase 3

Completed

Conditions: Hypokalemic Periodic Paralysis
Hyperkalemic Periodic Paralysis

Interventions: Drug: Dichlorphenamide (double-blind)
Drug: Placebo (double-blind)
Drug: Dichlorphenamide (open-label)

First Posted Date: 2007-06-29

Last Posted Date: 2017-06-14

Lead Sponsor: University of Rochester

Target Recruit Count: 71

Registration Number: NCT00494507

Locations: 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
University of Texas Southwestern-Dallas, Dallas, Texas, United States
🇺🇸
University of Rochester, Rochester, New York, United States

and more 9 locations

Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular Interventions

Phase 4

Completed

Conditions: Coronary Artery Disease
Peripheral Vascular Disease

First Posted Date: 2007-06-04

Last Posted Date: 2009-07-31

Lead Sponsor: University of Rochester

Target Recruit Count: 150

Registration Number: NCT00481741

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

Centocor Microarray Study of Patients

Phase 4

Completed

Conditions: Psoriatic Arthritis
Crohn's Disease
Psoriasis
Rheumatoid Arthritis

First Posted Date: 2007-04-18

Last Posted Date: 2015-04-29

Lead Sponsor: University of Rochester

Target Recruit Count: 31

Registration Number: NCT00462072

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Influenza Vaccine in Premature Infants

Completed

Conditions: Infant, Premature
Influenza

Interventions: Biological: Trivalent Inactivated Influenza Vaccine

First Posted Date: 2007-04-03

Last Posted Date: 2015-09-17

Lead Sponsor: University of Rochester

Target Recruit Count: 66

Registration Number: NCT00455169

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
State University of New York at Buffalo, Buffalo, New York, United States

and more 2 locations

NET-PD LS-1 Creatine in Parkinson's Disease

Phase 3

Terminated

Conditions: Parkinson's Disease

Interventions: Other: placebo
Drug: creatine

First Posted Date: 2007-03-21

Last Posted Date: 2015-04-02

Lead Sponsor: University of Rochester

Target Recruit Count: 1741

Registration Number: NCT00449865

Locations: 🇺🇸
Northshore-LIJ Health System, The Feinstein Institute FPR Medical Research, 350 Community Drive Room,, Manhasset, New York, United States
🇺🇸
Indiana University School Of Medicine, Outpatient Clinical Research Facility, 535 Barnhill Drive Room #150, Indianapolis, Indiana, United States
🇺🇸
Brigham & Women's Hospital, Neurology Department ASB2, 75 Francis Street, Boston, Massachusetts, United States

and more 47 locations

Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis

Phase 4

Terminated

Conditions: Chronic Pain
Multiple Sclerosis
Neuropathic Pain

Interventions: Drug: Lidocaine patch 5%
Drug: Extended-release oxycodone
Drug: Placebo extended-release oxycodone pills
Drug: Placebo lidocaine patches

First Posted Date: 2006-12-21

Last Posted Date: 2015-07-17

Lead Sponsor: University of Rochester

Target Recruit Count: 19

Registration Number: NCT00414453

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy